2138.HK
BuySecond WindFLAGEC Healthcare · Healthcare · Hong Kong · $61M · Avg Vol: $50K/d
Second Wind: Cheap and rising again, but the business does not yet earn the optimism.
Insufficient evidence for a screen-pass. EC Healthcare: fails the quant gate on quality, momentum (Q43/V76/M47; every leg must be >= 50). Absence of evidence is neutral; nothing adverse is known.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT EC HEALTHCARE
Read
EC Healthcare provides medical and healthcare services in Hong Kong, Macau, Mainland China, and Taiwan. It operates through three segments: Medical; Aesthetic Medical and Beauty and Wellness; and Veterinary and Other segments.
FINANCIAL SUMMARY (HKD)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 3.9B | 4.2B | 4.1B | 3.8B | -0.9% | 3.8B |
| EPS (HKD) | 0.06 | -0.02 | -0.14 | -0.34 | — | -0.34 |
| Shares | 1.2B | 1.2B | 1.2B | 1.2B | +0.4% | 1.2B |
| Debt | 1.5B | 1.6B | 1.3B | 1.3B | -6.4% | 1.3B |
| Equity | 1.9B | 2.0B | 1.8B | 1.4B | -9.3% | — |
| Op CF | 605.3M | 689.1M | 743.2M | 606.6M | 0.1% | 606.4M |
| Inv CF | -723.8M | -358.4M | 341.3M | -275.8M | — | — |
| Fin CF | -40.1M | -486.5M | -633.8M | -570.5M | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 2138.HK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 2138.HK | EC Healthcare(you) | $61M | 75 | Buy |
| 0648.HK | SoftMedx Healthcare Limited | $83M | 62 | Hold |
| 3309.HK | C-MER Medical Holdings Limited | $129M | 82 | Strong Buy |
| 2189.HK | Kato (Hong Kong) Holdings Limited | $63M | 97 | Strong Buy |
| 3886.HK | Town Health International Medical Group Limited | $149M | 47 | Hold |
| 1830.HK | Perfect Medical Health Management Limited | $210M | 100 | Strong Buy |
| 0690.HK | Uni-Bio Science Group Limited | $66M | 84 | Strong Buy |
| 1612.HK | Vincent Medical Holdings Limited | $58M | 92 | Strong Buy |
| 0950.HK | Lee's Pharmaceutical Holdings Limited | $101M | 84 | Strong Buy |
| 2161.HK | JBM (Healthcare) Limited | $192M | 89 | Strong Buy |
Peer medians: ROE 6.5% · P/E 10.5x · Gross margin 42.1%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.